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continued during the 2011-2012 inﬂuenza season, and the pending
results will be reported in our presentation.
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Conclusion: CTX-M-15 is the most common CTX-M genotype
ound in this study and this is the ﬁrst report on the emergence
f O25-ST131 clones in Malaysian E.coli isolates. Another common
equence type (ST354) for ESBL-producing E. coli was observed
hich has been reported. Other ESBL-producing E.coli isolateswere
enetically diverse as they shared different sequence types.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.573
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ynergistic effects of sodium chenodeoxycholic acid on antimi-
robial activities of -lactam antibiotics against -lactamase-
roducing Staphylococcus aureus
. Horie1,∗, A. Yamada2
Ohu University, Fukushima, Japan
The University of Shiga Prefecture, Shiga, Japan
Background: -lactamase-producing Staphylococcus aureus
ynthesizes a -lactamase which decomposes the -lactam ring,
nd consequently almost all -lactam antibiotics are inactivated
y the enzyme. The appearance of -lactamase-producing bacte-
ial strains has diminished the usefulness of -lactam antibiotics.
ew therapeutic agents or newapproaches are urgently needed for
rug-resistant bacteria. We investigated the antimicrobial activity
f sodium chenodeoxycholic acid against -lactamase-producing
. aureus strains, and the synergistic effects of sodium chenodeoxy-
holic acid on the antimicrobial activity of -lactam antibiotics
gainst those strains. The possibility of this combination as a
ew therapeutic method against infectious diseases caused by -
actamase-producing bacteria was examined.
Methods: The synergistic effects of the combined use of sodium
henodeoxycholic acid on the antimicrobial activities of -lactam
ntibiotics, including benzylpenicillin, ampicillin, amoxicillin and
iperacillin, against ﬁve isolates of penicillinase-producing S.
ureus were tested by using an MIC (minimum inhibitory concen-
ration) assay. The inhibitory effects on the penicillinase activity
nd on the synthesis of the penicillinase in penicillinase-producing
. aureus by sodium chenodeoxycholic acid were examined by
itroceﬁn assay.
Results: The MIC range of the four -lactams against
enicillinase-producing S. aureus strains was 32 to 128 g/mL. On
he other hand, the range of the combined use of sodium chen-
deoxycholic acid was 0.5 to 4 g/mL. The antimicrobial activities
f -lactam antibiotics to the strains were obviously enhanced by
he combination with sodium chenodeoxycholic acid. In addition,
t was demonstrated that the sodium chenodeoxycholic acid sig-
iﬁcantly reduced (p<0.01) the synthesis of the penicillinase in
enicillinase-producing S. aureus, but did not suppress the peni-
illinase activity.
Conclusion: Chenodeoxycholic acid have already been used
egularly as cholagogue, a choleretic laxative, and to prevent or dis-
olve gallstones in the medical practice. Therefore, there is hardly
ny problem in safety for the human body. Although further anal-
sis is necessary, investigation of the synergistic effects of sodium
henodeoxycholic acid on the antimicrobial activity is expected to
eanewtherapeuticmethodandmaycontribute toaneffectiveuti-fectious Diseases 16S (2012) e317–e473 e417
lization of -lactam antibiotics against infectious diseases caused
by -lactamase-producing bacteria.
http://dx.doi.org/10.1016/j.ijid.2012.05.574
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Background: In the 2010-2011 inﬂuenza season, four neu-
raminidase inhibitors (NAIs), oseltamivir phosphate (Tamiﬂu®),
zanamivir (Relenza®), laminamivir octanoate (Inavir®), and
peramivir (Rapiacta®), were available for the treatment of
inﬂuenza in Japan. To study the extent of drug resistance to each
NAI, wemeasure the halfmaximal inhibitory concentrations (IC50)
of the four NAIs with inﬂuenza viruses isolated in the 2010-2011
and 2011-2012 inﬂuenza seasons.
Methods: Inﬂuenza viruses were isolated from nasal aspiration,
nasopharyngeal swab, or self-blown nasal discharge obtained from
patients before treatment. Madine-Darby canine kidney cells were
used for viral isolation. The type and subtypes of A(H1N1)pdm09,
H3N2 or B were determined by RT-PCR using type and subtype
speciﬁc primers. The IC50 was determined by a ﬂuorescence-based
neuraminidase inhibition assay. NA sequences were directly deter-
mined from clinical samples.
Results: A(H1N1)pdm09, H3N2, and B viruses were isolated
in the 2010-2011 season from 185, 54, and 30 patients, respec-
tively. The geometric means of IC50 for oseltamivir carboxylate
were 0.86 nM, 0.73 nM, and 33.12 nM for A(H1N1)pdm09, H3N2,
and B, respectively. Similarly, the geometric means of IC50 for the
other three NAIs were lowest for A(H1N1)pdm09 and highest for B
viruses. TwooutlierA(H1N1)pdm09 isolates showedveryhigh IC50
values for oseltamivir (840 nM and 600 nM) and peramivir (19 nM
and 24 nM). H275Y mutation was found in both of these isolates.
No isolates showed signiﬁcantly high IC50 values for zanamivir or
laninamivir.
Conclusion:A(H1N1)pdm09 isolates obtained in the2010-2011
season from2of 269 patients showed signiﬁcantly high IC50 values
for oseltamivir carboxylate and peramivir. In contrast, all isolates
were sensitive to zanamivir and laninamivir. The study is being
